Biocorp and novo nordisk strengthen their partnership with a new agreement on mallya® smart sensor

Issoire, france--(business wire)-- #digitalhealth--regulatory news: biocorp (fr0012788065 – alcor / eligible pea‐pme) (paris:alcor), a french company specialized in the design, development, and manufacturing of innovative medical devices, announces the signature of a partnership agreement with novo nordisk for the commercialization of mallya, initially in japan.
NVO Ratings Summary
NVO Quant Ranking